Nonfactor therapies may reduce costs associated with bleeding-related hospitalizations and use of bypassing agents. One study ...

Specialty drugs, especially biologics, will constitute a significant portion of global drug spending by 2029, driven by cancer care costs. Autoimmune diseases and multiple sclerosis are key short-term ...

HPV vaccine remains effective in preventing infections and related cancers, even with incomplete dosing, 17 years after its ...

They found that the automated diabetes GLP-1 prior authorization proportion of all diabetes GLP-1 claims grew by 17.5 percentage points, or 39.6%, from October 2024 to July 2025.

An expert discusses the critical need for a holistic, multidisciplinary approach to prevent and manage interconnected ...

Among chemotherapy-naive patients, elacestrant extended median progression-free survival compared with standard therapy, ...

AI models outperform traditional rule-based systems in identifying high-risk patients by integrating diverse data sources and ...

Early childhood stress, especially before age 1, significantly increases psoriasis risk, with an odds ratio of 4.19. The study involved over 16,000 children, using data from the All Babies in ...

Dry eye treatments include over-the-counter eye drops and prescription medicines. The AMCP abstract included immunomodulators ...

In the VALOR trial, brepocitinib 30 mg demonstrated clinically meaningful and statistically significant improvement compared ...

Prime researchers found that the CAR T cohort had a significantly higher average total cost of care compared with the BiTE cohort: $702,000 vs. $372,000. Among the studied therapies, drug costs were ...

Type A botulinum, commonly reffered to as botox, was approved by FDA in 2002 for cosmetic use to reduce fine lines and ...